1. The European Parliament and the Council of the European Union. Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official J. Eur. Union 10.12.2007, L324/121–L324/137 (2007).
2. The European Parliament and the Council of the European Union. Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products. Official J. Europ. Union 15.9.2009, L242/3–L242/12 (2009).
3. Aiuti, A. et al. Gene therapy for immunodeficiency due to adenosine deaminase deficienty. N. Engl. J. Med. 360, 447–458 (2009).
4. Kohn, D. B. & Candotti, F. Gene therapy fulfilling its promise. N. Engl. J. Med. 360, 518–521 (2009).
5. Bainbridge, J. W. et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358, 2231–2239 (2009).